Stock market eyes Q2 results from beauty giant Nykaa, retail major Trent, metals powerhouse Hindalco and other key companies. Get complete analysis of what to expect from these earnings declarations.
A high-stakes White House meeting on weight-loss drug prices took a dramatic turn when a pharmaceutical executive suddenly collapsed, forcing an abrupt end to Donald Trump's briefing. The viral video has sparked nationwide concern.
Former President Donald Trump reveals groundbreaking agreement with pharmaceutical giants to dramatically reduce costs of popular weight loss medications, promising relief for millions struggling with obesity.
In a major victory for American patients, pharmaceutical titans Eli Lilly and Novo Nordisk announce significant price reductions for popular weight-loss medications after Trump's intervention.
Indian pharmaceutical companies are reporting exceptional earnings driven by US generic drug sales, leading to major fundraising initiatives for expansion into medtech and wellness sectors.
British-Swedish pharma giant AstraZeneca reports blockbuster Q3 results with profits surging 77% to $2.53 billion, driven by robust cancer drug sales and strategic US market expansion.
Piramal Pharma anticipates significant growth as US biopharma funding shows recovery signs, with CDMO business poised for major expansion.
Kotak Securities report reveals stellar Q2 FY2025 results with metals and OMCs leading earnings beat. Discover which sectors exceeded estimates and the outlook for Indian markets.
In a significant crackdown, the Directorate of Revenue Intelligence dismantled a sophisticated drug factory in Gujarat's Valsad district, seizing massive quantities of Alprazolam worth crores and arresting key operatives.
Investors brace for a high-stakes earnings Thursday as insurance giant LIC, EV pioneer Ola Electric, and pharma major Lupin headline over 20 companies declaring Q2 FY2025 results. Get expert insights on what to expect.
Danish pharmaceutical giant Novo Nordisk faces turbulent times as Q3 profits drop 27% despite Ozempic's success. The company announces massive restructuring with 9,000 job cuts worldwide. Get the inside story on what's happening behind the scenes.
Solara Active Pharma Sciences faces challenging quarter with ₹10 crore net loss despite revenue growth. Discover the operational challenges and management's recovery strategy.
India's pharmaceutical giant Sun Pharma reports steady Q2 growth with 9% revenue increase while navigating US market challenges. Key insights from their latest earnings report.
Market eyes Wednesday's Q2 earnings bonanza as pharma giant Sun Pharma, Grasim Industries, and FMCG major Britannia declare results. Get complete analysis and investor expectations.
Adani Enterprises reports stellar Q2 performance with 130% profit surge to ₹228 crore, driven by airport operations and green hydrogen initiatives, while coal trading faces headwinds.
Discover how AgentForce's AI-powered platform is reshaping customer engagement in India's life sciences sector, eliminating burnout while boosting productivity by 40%.
CPaaS leader Route Mobile faces surprising Q2 setback with ₹19 crore loss versus last year's profit. Revenue growth stalls at 0.7% amid global economic pressures. Discover what went wrong.
Himachal Pradesh drug control authorities raid Baddi pharmaceutical facility after Rajasthan complaints reveal distribution of sub-standard medicines across seven districts, raising serious public health concerns.
Stock market braces for earnings tsunami as State Bank of India, Adani Enterprises, Mahindra & Mahindra, and Paytm parent One 97 Communications lead today's Q2 results declaration. Get complete analysis and market expectations.
Indian vaccine maker Bharat Biotech expands into high-growth CRDMO space with new subsidiary Nucelion Therapeutics, focusing on cutting-edge cell and gene therapies for cancer and rare diseases.
Major Indian companies including Bharti Airtel, Titan Company, and Power Grid Corporation are set to declare their Q2 FY2025 earnings today. Get insights into market expectations, key metrics to watch, and how these results could impact your investment de
Indian exports to the US plummeted 37.5% amid 50% Trump tariffs, with smartphones and pharmaceuticals taking the biggest hit. Get the complete trade impact analysis.
GTRI report reveals devastating 37.5% decline in India's key exports to US, with smartphones, pharmaceuticals, and gems taking the hardest hit from American tariff policies.
As the US government shutdown extends to record length, Wall Street shifts focus to Q3 corporate earnings. Discover how this political stalemate impacts market sentiment and investor strategy.
Get ready for a blockbuster week in Indian markets as corporate giants including Bharti Airtel, SBI, LIC, Paytm, and Adani Enterprises declare their Q2 FY2025 results. Discover key expectations and market-moving insights.
Stock market investors brace for major Q2 earnings announcements as Urban Company, Tata Chemicals and 25 other companies set to reveal financial performance today. Get complete list and analysis.
Multiple blood pressure medications recalled after FDA detects potential cancer-causing impurities. Find out if your medication is affected and what steps to take immediately.
Indian biopharmaceutical leader Health Biotech Limited makes waves at CPhI Frankfurt 2025, showcasing innovative products and forging international partnerships to strengthen its global market position.
Chandigarh-based Niner Pharma announces massive R&D expansion with 125 novel peptide molecules targeting wellness and cosmetic innovation, positioning India as global leader in peptide research.
Major Indian companies including Maruti Suzuki, Vedanta, BEL, BPCL, and GAIL are announcing their Q2 FY2025 earnings today. Get insights on expected performance, key financial indicators, and market impact analysis.